These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 25430085)
1. Identification of a homozygous JAK3 V674A mutation caused by acquired uniparental disomy in a relapsed early T-cell precursor ALL patient. Kawashima-Goto S; Imamura T; Seki M; Kato M; Yoshida K; Sugimoto A; Kaneda D; Fujiki A; Miyachi M; Nakatani T; Osone S; Ishida H; Taki T; Takita J; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Ogawa S; Hosoi H Int J Hematol; 2015 Apr; 101(4):411-6. PubMed ID: 25430085 [TBL] [Abstract][Full Text] [Related]
2. Mutant JAK3 signaling is increased by loss of wild-type JAK3 or by acquisition of secondary JAK3 mutations in T-ALL. Degryse S; Bornschein S; de Bock CE; Leroy E; Vanden Bempt M; Demeyer S; Jacobs K; Geerdens E; Gielen O; Soulier J; Harrison CJ; Constantinescu SN; Cools J Blood; 2018 Jan; 131(4):421-425. PubMed ID: 29187379 [TBL] [Abstract][Full Text] [Related]
3. Immunophenotypic but Not Genetic Changes Reclassify the Majority of Relapsed/Refractory Pediatric Cases of Early T-Cell Precursor Acute Lymphoblastic Leukemia. Demina I; Dagestani A; Borkovskaia A; Semchenkova A; Soldatkina O; Kashpor S; Olshanskaya Y; Roumiantseva J; Karachunskiy A; Novichkova G; Maschan M; Zerkalenkova E; Popov A Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891797 [TBL] [Abstract][Full Text] [Related]
4. Molecular allelokaryotyping of relapsed pediatric acute lymphoblastic leukemia. Kawamata N; Ogawa S; Seeger K; Kirschner-Schwabe R; Huynh T; Chen J; Megrabian N; Harbott J; Zimmermann M; Henze G; Schrappe M; Bartram CR; Koeffler HP Int J Oncol; 2009 Jun; 34(6):1603-12. PubMed ID: 19424578 [TBL] [Abstract][Full Text] [Related]
5. Deep sequencing and SNP array analyses of pediatric T-cell acute lymphoblastic leukemia reveal NOTCH1 mutations in minor subclones and a high incidence of uniparental isodisomies affecting CDKN2A. Karrman K; Castor A; Behrendtz M; Forestier E; Olsson L; Ehinger M; Biloglav A; Fioretos T; Paulsson K; Johansson B J Hematol Oncol; 2015 Apr; 8():42. PubMed ID: 25903014 [TBL] [Abstract][Full Text] [Related]
6. Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia. Bains T; Heinrich MC; Loriaux MM; Beadling C; Nelson D; Warrick A; Neff TL; Tyner JW; Dunlap J; Corless CL; Fan G Leukemia; 2012 Sep; 26(9):2144-6. PubMed ID: 22425895 [No Abstract] [Full Text] [Related]
7. Failure of tofacitinib to achieve an objective response in a Wong J; Wall M; Corboy GP; Taubenheim N; Gregory GP; Opat S; Shortt J Cold Spring Harb Mol Case Stud; 2020 Aug; 6(4):. PubMed ID: 32843425 [TBL] [Abstract][Full Text] [Related]
14. Identification of a constitutively active mutant of JAK3 by retroviral expression screening. Choi YL; Kaneda R; Wada T; Fujiwara S; Soda M; Watanabe H; Kurashina K; Hatanaka H; Enomoto M; Takada S; Yamashita Y; Mano H Leuk Res; 2007 Feb; 31(2):203-9. PubMed ID: 16790275 [TBL] [Abstract][Full Text] [Related]
15. JAK3 pathway is constitutively active in B-lineage acute lymphoblastic leukemia. Uckun FM; Pitt J; Qazi S Expert Rev Anticancer Ther; 2011 Jan; 11(1):37-48. PubMed ID: 21070101 [TBL] [Abstract][Full Text] [Related]
16. IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study. Li Y; Buijs-Gladdines JG; Canté-Barrett K; Stubbs AP; Vroegindeweij EM; Smits WK; van Marion R; Dinjens WN; Horstmann M; Kuiper RP; Buijsman RC; Zaman GJ; van der Spek PJ; Pieters R; Meijerink JP PLoS Med; 2016 Dec; 13(12):e1002200. PubMed ID: 27997540 [TBL] [Abstract][Full Text] [Related]
17. Suz12 inactivation cooperates with JAK3 mutant signaling in the development of T-cell acute lymphoblastic leukemia. Broux M; Prieto C; Demeyer S; Vanden Bempt M; Alberti-Servera L; Lodewijckx I; Vandepoel R; Mentens N; Gielen O; Jacobs K; Geerdens E; Vicente C; de Bock CE; Cools J Blood; 2019 Oct; 134(16):1323-1336. PubMed ID: 31492675 [TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of somatically acquired and constitutive uniparental disomy in gastrointestinal cancers. Torabi K; Erola P; Alvarez-Mora MI; Díaz-Gay M; Ferrer Q; Castells A; Castellví-Bel S; Milà M; Lozano JJ; Miró R; Ried T; Ponsa I; Camps J Int J Cancer; 2019 Feb; 144(3):513-524. PubMed ID: 30350313 [TBL] [Abstract][Full Text] [Related]
19. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Zhang J; Ding L; Holmfeldt L; Wu G; Heatley SL; Payne-Turner D; Easton J; Chen X; Wang J; Rusch M; Lu C; Chen SC; Wei L; Collins-Underwood JR; Ma J; Roberts KG; Pounds SB; Ulyanov A; Becksfort J; Gupta P; Huether R; Kriwacki RW; Parker M; McGoldrick DJ; Zhao D; Alford D; Espy S; Bobba KC; Song G; Pei D; Cheng C; Roberts S; Barbato MI; Campana D; Coustan-Smith E; Shurtleff SA; Raimondi SC; Kleppe M; Cools J; Shimano KA; Hermiston ML; Doulatov S; Eppert K; Laurenti E; Notta F; Dick JE; Basso G; Hunger SP; Loh ML; Devidas M; Wood B; Winter S; Dunsmore KP; Fulton RS; Fulton LL; Hong X; Harris CC; Dooling DJ; Ochoa K; Johnson KJ; Obenauer JC; Evans WE; Pui CH; Naeve CW; Ley TJ; Mardis ER; Wilson RK; Downing JR; Mullighan CG Nature; 2012 Jan; 481(7380):157-63. PubMed ID: 22237106 [TBL] [Abstract][Full Text] [Related]
20. Novel JAK3-Activating Mutations in Extranodal NK/T-Cell Lymphoma, Nasal Type. Sim SH; Kim S; Kim TM; Jeon YK; Nam SJ; Ahn YO; Keam B; Park HH; Kim DW; Kim CW; Heo DS Am J Pathol; 2017 May; 187(5):980-986. PubMed ID: 28284718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]